Page last updated: 2024-10-06

SUMOylation of intracellular receptors

Proteins (24)

ProteinSynonymsTaxonomy
Small ubiquitin-related modifier 2SUMO-2; HSMT3; SMT3 homolog 2; SUMO-3; Sentrin-2; Ubiquitin-like protein SMT3B; Smt3BHomo sapiens (human)
Small ubiquitin-related modifier 1SUMO-1; GAP-modifying protein 1; GMP1; SMT3 homolog 3; Sentrin; Ubiquitin-homology domain protein PIC1; Ubiquitin-like protein SMT3C; Smt3C; Ubiquitin-like protein UBL1Homo sapiens (human)
Estrogen receptorER; ER-alpha; Estradiol receptor; Nuclear receptor subfamily 3 group A member 1Homo sapiens (human)
Glucocorticoid receptorGR; Nuclear receptor subfamily 3 group C member 1Homo sapiens (human)
Mineralocorticoid receptor MR; Nuclear receptor subfamily 3 group C member 2Homo sapiens (human)
Androgen receptorDihydrotestosterone receptor; Nuclear receptor subfamily 3 group C member 4Homo sapiens (human)
Vitamin D3 receptorVDR; 1,25-dihydroxyvitamin D3 receptor; Nuclear receptor subfamily 1 group I member 1Homo sapiens (human)
Nuclear receptor ROR-alphaNuclear receptor RZR-alpha; Nuclear receptor subfamily 1 group F member 1; RAR-related orphan receptor A; Retinoid-related orphan receptor-alphaHomo sapiens (human)
Peroxisome proliferator-activated receptor gammaPPAR-gamma; Nuclear receptor subfamily 1 group C member 3Homo sapiens (human)
Oxysterols receptor LXR-betaLiver X receptor beta; Nuclear receptor NER; Nuclear receptor subfamily 1 group H member 2; Ubiquitously-expressed nuclear receptorHomo sapiens (human)
Histone deacetylase 4HD4; EC 3.5.1.98Homo sapiens (human)
Nuclear receptor subfamily 4 group A member 2Immediate-early response protein NOT; Orphan nuclear receptor NURR1; Transcriptionally-inducible nuclear receptorHomo sapiens (human)
Steroidogenic factor 1SF-1; STF-1; hSF-1; Adrenal 4-binding protein; Fushi tarazu factor homolog 1; Nuclear receptor subfamily 5 group A member 1; Steroid hormone receptor Ad4BPHomo sapiens (human)
Progesterone receptorPR; Nuclear receptor subfamily 3 group C member 3Homo sapiens (human)
Retinoic acid receptor RXR-alphaNuclear receptor subfamily 2 group B member 1; Retinoid X receptor alphaHomo sapiens (human)
Peroxisome proliferator-activated receptor alphaPPAR-alpha; Nuclear receptor subfamily 1 group C member 1Homo sapiens (human)
E3 SUMO-protein ligase PIAS1EC 2.3.2.-; DEAD/H box-binding protein 1; E3 SUMO-protein transferase PIAS1; Gu-binding protein; GBP; Protein inhibitor of activated STAT protein 1; RNA helicase II-binding proteinHomo sapiens (human)
Retinoic acid receptor alphaRAR-alpha; Nuclear receptor subfamily 1 group B member 1Homo sapiens (human)
Thyroid hormone receptor betaNuclear receptor subfamily 1 group A member 2; c-erbA-2; c-erbA-betaHomo sapiens (human)
Nuclear receptor subfamily 2 group C member 1Orphan nuclear receptor TR2; Testicular receptor 2Homo sapiens (human)
SUMO-conjugating enzyme UBC9EC 2.3.2.-; RING-type E3 SUMO transferase UBC9; SUMO-protein ligase; Ubiquitin carrier protein 9; Ubiquitin carrier protein I; Ubiquitin-conjugating enzyme E2 I; Ubiquitin-protein ligase I; p18Homo sapiens (human)
Small ubiquitin-related modifier 3SUMO-3; SMT3 homolog 1; SUMO-2; Ubiquitin-like protein SMT3A; Smt3AHomo sapiens (human)
E3 SUMO-protein ligase PIAS3EC 2.3.2.-; E3 SUMO-protein transferase PIAS3; Protein inhibitor of activated STAT protein 3Homo sapiens (human)
E3 SUMO-protein ligase PIAS4EC 2.3.2.27; PIASy; Protein inhibitor of activated STAT protein 4; Protein inhibitor of activated STAT protein gamma; PIAS-gamma; RING-type E3 ubiquitin transferase PIAS4Homo sapiens (human)

Compounds (1)

CompoundDescription
rifampinA semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)